- Home
- PHVS vs HLIO Comparison
PHVS vs HLIO Comparison
Compare PHVS & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- HLIO
- Stock Information
- Founded
- PHVS 2015
- HLIO 1970
- Country
- PHVS Switzerland
- HLIO United States
- Employees
- PHVS N/A
- HLIO N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- HLIO Metal Fabrications
- Sector
- PHVS Health Care
- HLIO Industrials
- Exchange
- PHVS Nasdaq
- HLIO Nasdaq
- Market Cap
- PHVS 1.6B
- HLIO 1.8B
- IPO Year
- PHVS 2021
- HLIO N/A
- Fundamental
- Price
- PHVS $22.08
- HLIO $56.86
- Analyst Decision
- PHVS Buy
- HLIO Strong Buy
- Analyst Count
- PHVS 6
- HLIO 5
- Target Price
- PHVS $36.50
- HLIO $47.60
- AVG Volume (30 Days)
- PHVS 217.1K
- HLIO 311.3K
- Earning Date
- PHVS 11-12-2025
- HLIO 11-03-2025
- Dividend Yield
- PHVS N/A
- HLIO 0.63%
- EPS Growth
- PHVS N/A
- HLIO 17.55
- EPS
- PHVS N/A
- HLIO 1.05
- Revenue
- PHVS N/A
- HLIO $782,000,000.00
- Revenue This Year
- PHVS N/A
- HLIO $3.85
- Revenue Next Year
- PHVS N/A
- HLIO $2.60
- P/E Ratio
- PHVS N/A
- HLIO $54.82
- Revenue Growth
- PHVS N/A
- HLIO N/A
- 52 Week Low
- PHVS $11.51
- HLIO $24.76
- 52 Week High
- PHVS $26.33
- HLIO $57.61
- Technical
- Relative Strength Index (RSI)
- PHVS 49.23
- HLIO 63.88
- Support Level
- PHVS $22.38
- HLIO $56.11
- Resistance Level
- PHVS $23.64
- HLIO $57.61
- Average True Range (ATR)
- PHVS 1.28
- HLIO 1.93
- MACD
- PHVS 0.04
- HLIO 0.57
- Stochastic Oscillator
- PHVS 61.27
- HLIO 98.39
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.